Preparation and In Vitro/In Vivo Evaluation of Luteinizing Hormone Releasing Hormone (LHRH)-Loaded Polyhedral and Spherical/Tubular Niosomes
- 1 January 1999
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 88 (1) , 34-38
Abstract
Niosomes are vesicles formed by the self-assembly of nonionic surfactants in aqueous dispersions. They can entrap drugs and have been used experimentally as sustained drug delivery systems. Apart from conventional spherical niosomes, various types of vesicle ultrastructures can be formed by varying the composition of the vesicle membrane. Hexadecyl diglycerol ether (C16G2), cholesterol, and poly-24-oxyethylene cholesteryl ether (Solulan C24) in the ratio 91:0:9 gave polyhedral niosomes, whereas spherical and tubular niosomes are produced at a composition ratio of 49:49:2. The mean size of both polyhedral and spherical/tubular niosomes were within the range of 6 to 9 microm. Both types of vesicle were visualized by cryo-scanning electron microscopy. The properties of the two forms of niosomes were studied using luteinizing hormone releasing hormone (LHRH) as a model peptide. Analysis by high-performance liquid chromatography demonstrated high entrapment of LHRH acetate in polyhedral niosomes when prepared by remote loading methods using pH or (NH4)2SO4 gradients; in contrast, only low entrapment was achieved by passive loading methods (direct hydration at pH 7.4 or pH 3.0, dehydration-rehydration, and reversed-phase evaporation). In vitro studies demonstrated that both polyhedral and spherical/tubular niosomes were more stable in 5% rat skeletal muscle homogenate than in rat plasma. Also, polyhedral niosomes released more radiolabeled LHRH ([125I]LHRH) than spherical/tubular niosomes in both muscle homogenate and plasma. In clearance experiments in the rat, following intramuscular injection, both polyhedral and spherical/tubular niosomes gradually released [125I]LHRH into the blood, but some radioactivity remained at the injection site for 25 and 49 h, respectively. In contrast, [125I]LHRH in phosphate buffered saline was completely cleared from the injection site at 2 h. The release of drug is sustained by both niosome formulations, but spherical/tubular niosomes possess more stable membranes than polyhedral niosomes due to the presence of cholesterol.Keywords
This publication has 9 references indexed in Scilit:
- Polyhedral Non-ionic Surfactant VesiclesJournal of Pharmacy and Pharmacology, 1997
- Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistryAdvances in Colloid and Interface Science, 1995
- Release and absorption rates of intramuscularly and subcutaneously injected pharmaceuticals (II)International Journal of Pharmaceutics, 1994
- Parenteral Peptide Formulations: Chemical and Physical Properties of Native Luteinizing Hormone-Releasing Hormone (LHRH) and Hydrophobic Analogues in Aqueous SolutionPharmaceutical Research, 1991
- The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a surveyChemistry and Physics of Lipids, 1990
- Liposome encapsulation of doxorubicin: Pharmaceutical and therapeutic aspectsJournal of Controlled Release, 1989
- Effect of Human Plasma on the Stability of Large Multilamellar Liposomes with DigitoxinDrug Development and Industrial Pharmacy, 1989
- Role of peptide structure in lipid-peptide interactions: high-sensitivity differential scanning calorimetry and electron spin resonance studies of the structural properties of dimyristoylphosphatidylcholine membranes interacting with pentagastrin-related pentapeptidesBiochemistry, 1985
- The stability of a prodrug, liposome and a prodrug-liposome complex in simulated biological conditionsInternational Journal of Pharmaceutics, 1983